Last reviewed · How we verify
NCT05569642
Cluster Analysis to Identify Metabolic Syndrome Components and Physical Fitness in Patients With Metabolic Syndrome
trial in Metabolic Syndrome in 112 participants. Completed in 27 December 2023.
27 October 2022
Quick facts
| Lead sponsor | Istanbul Galata University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 112 |
| Start date | 13 June 2022 |
| Primary completion | 27 October 2022 |
| Estimated completion | 27 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
Istanbul Galata University
Who can join
Adults 40 to 65, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The components of MetS (abdominal obesity, high blood pressure, high serum glucose, high triglyceride level and low HDL-C) differ according to demographic characteristics such as age, gender and comorbidities. Low physical activity level, genetic makeup, nutritional disorders, decreased muscle strength and low cardiorespiratory fitness can be counted among the risk factors associated with MetS. In our study, it was aimed to examine the relationship between the components of the MetS and muscle strength, physical activity, functional capacity and quality of life. Our secondary aim is to investigate the independent effects of different components of MetS on each parameter.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05569642
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other Istanbul Galata University trials
Trials by the same sponsor.
- NCT07206381 — Effects of EMDR on Psychological Symptoms and EEG Findings in Trauma-Exposed Individuals · NA · not yet recruiting
- NCT06581770 — Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Differ · recruiting
- NCT06520956 — Improving the Quality of Life of Elderly Individuals Living in Nursing Homes · NA · active not recruiting
- NCT06829576 — Examining Health-related Physical Fitness in Individuals With Diabetic Dyslipidemia. · completed
- NCT05657600 — Effectiveness of Video-based Yoga Practices for Sedentary Women in Pandemic Days · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05569642 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Galata University
- Last refreshed: 24 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05569642.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing